Sensex rises! But these stocks fell 5% or more in Friday's sessionIn the Nifty pack, 30 stocks closed in the green, while 20 stocks ended in the red.
PharmEasy SOS: plans rights issue at 90% discount to repay loan; Cabinet approves Digital Personal Data billThe online drugstore plans to swallow a bitter pill in the hope that it can heal itself. The distress rights issue, if it goes through, wil...
PharmEasy plans rights issue at 90% valuation cut; Amazon set to hit $8B India exportsEarlier in the day we broke the news that PharmEasy’s investors have taken control of the company as they plan a Rs 2,400 crore rights issu...
In 2022, etailers trumped offline stores in smartphone shipments; PharmEasy rules out Thyrocare saleThe calendar year 2022 saw online platforms like Flipkart, Amazon overtake offline retailers in shipments of smartphones from manufacturing...
State can't curtail fundamental right to establish educational institutes by executive order: SCWhile dismissing the pleas of the PCI, the bench, however, said the applications seeking approval for pharmacy courses are required to be a...
RDIF says early results of 'mix & match' of Sputnik Light, AstraZeneca jab found to be safeAstraZeneca COVID vaccine is the same as Covishield which is used in India and several other countries.
Build a Tech-Driven Career in Healthcare with Pharmaceutical Management at NMIMS
Big promises, few doses: Why Russia's struggling to make Sputnik V dosesPresident Vladimir Putin has trumpeted the vaccine around the world, and said in March that Russia had signed agreements for the production...
India among 20 countries interested in obtaining Covid-19 vaccine from RussiaRDIF has seen strong global interest in the vaccine and plans to conduct Phase 3 clinical trials in different countries, including Saudi Ar...
In Russia, a black market for HIV drug to try on coronavirusA black market has developed in Russia for an antiviral HIV drug explored as a possible treatment for COVID-19, the respiratory disease cau...
Buy Torrent Pharmaceuticals, target Rs 1,560: IIFLBuy Torrent Pharmaceuticals Ltd. at a price target of Rs 1560.0 .
Torrent Pharma buys US firm Bio-PharmTorrent Pharma said it plans further investments to expand the BPI facilities, including its research and development (R&D) capabilities, a...
Market Now: These stocks hit fresh 52-week high on NSEStocks such as Gemini Comm, Glenmark Pharma, Ybrant Digital touched their fresh 52-week low.
Recruitments in India to rise 14.5% in 2016: ReportIndian companies are expected to create 14.5% more new jobs this year than in 2015 with the pharmaceuticals and healthcare industry leading...
- Aanjaneya Lifecare gets Rs 60 cr order for making cough syrup
Bulk drug maker said it has received orders worth Rs 60 cr from Wockhardt and Cipla, for manufacturing cough syrup 'Recodex'.
- Dr Reddy's inks pact with Russian firm R-Pharm
Commenting on the pact, R-Pharm Chairman Alexey Repik said, "This agreement helps address unmet medical needs in important therapeutic area...
- Admissions to begin next yr: BITS Hy'bad
The Hyderabad campus of Birla Institute of Technology and Science (BITS), an elite private institution of higher education, will start its ...